Eric Vandeloise
About Eric Vandeloise
Eric Vandeloise is the Associate Director of Global Clinical Operations and Strategy at Bristol-Myers Squibb with over fifteen years of experience in clinical research and development.
Current Role at Bristol-myers Squibb
Eric Vandeloise is currently serving as the Associate Director of Global Clinical Operations and Strategy at Bristol-myers Squibb located in New Jersey, United States. His role involves overseeing global clinical operations and developing strategic initiatives within the clinical department. This position highlights his extensive experience and leadership within the pharmaceutical industry.
Previous Roles at Bristol-myers Squibb
Prior to his current position, Eric Vandeloise held multiple roles at Bristol-myers Squibb. He was the Associate European Medical Lead for HIV from 2010 to 2011, based in New Jersey, United States. Before that, he served as a Senior Clinical Protocol Manager from 2005 to 2010, where he contributed to the management and development of clinical protocols.
Experience at Eli Lilly and Company
Eric Vandeloise's career includes significant experience at Eli Lilly and Company in Indianapolis, Indiana, United States. He worked as a Senior Clinical Development Associate from 2004 to 2005 and as a Clinical Pharmacology Coordinator from 2002 to 2004. His initial role at Eli Lilly was as a Clinical Data Coordinator from 2000 to 2002. These roles involved various responsibilities in clinical development and pharmacology.
Early Career and Research Background
Before joining the pharmaceutical industry, Eric Vandeloise gained experience at Institut Jules Bordet in Belgium, where he worked as Data Manager and Clinical Research Associate from 1999 to 2000. He also pursued a research and PhD position at Unamur in Namur, Belgium, from 1996 to 1998. This early career experience laid a solid foundation for his subsequent roles in clinical research and development.
Expertise in Clinical Research and Development
Eric Vandeloise has over fifteen years of experience in clinical research and development, encompassing all phases and therapeutic areas. His skills include cross-functional supervision of project teams, timeline and budget planning, and optimization of resource allocation. He also has robust operational knowledge in clinical trial management systems (CTMS) and electronic data capture (EDC), along with training in Lean Six-Sigma methodologies.